<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">lvrach</journal-id><journal-title-group><journal-title xml:lang="ru">Лечащий Врач</journal-title><trans-title-group xml:lang="en"><trans-title>Lechaschi Vrach</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-5175</issn><issn pub-type="epub">2687-1181</issn><publisher><publisher-name>ООО «Издательство "Открытые системы"»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26295/OS.2020.29.28.010</article-id><article-id custom-type="elpub" pub-id-type="custom">lvrach-176</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Неврологические и психологические аспекты склеродермии лица и шеи у детей</article-title><trans-title-group xml:lang="en"><trans-title>Neurological and psychological aspects of scleroderma of the face and neck in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлова</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlova</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хачатрян</surname><given-names>Л. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Khachatryan</surname><given-names>L. G.</given-names></name></name-alternatives><bio xml:lang="en"><p>Doctor of Medicine, Professor,</p><p>Moscow</p></bio><email xlink:type="simple">ashdin@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осминина</surname><given-names>М. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Osminina</surname><given-names>M. K.</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD in Medicine,</p><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Геппе</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Geppe</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="en"><p>Doctor of Medicine, Professor,</p><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Подчерняева</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Podchernyaeva</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="en"><p>Doctor of Medicine, Professor,</p><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трепилец</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Trepilets</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богданова</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdanova</surname><given-names>M. D.</given-names></name></name-alternatives><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Касанаве</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kasanave</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюрина</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tjurina</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD in Medicine,</p><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Великорецкая</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Velikoretskaya</surname><given-names>M. D.</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD in Medicine,</p><p>Moscow</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый МГМУ им. И. М. Сеченова МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N. I. Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>06</month><year>2021</year></pub-date><volume>0</volume><issue>8</issue><fpage>61</fpage><lpage>65</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Павлова М.С., Хачатрян Л.Г., Осминина М.К., Геппе Н.А., Подчерняева Н.С., Трепилец В.М., Богданова М.Д., Касанаве Е.В., Тюрина Е.Н., Великорецкая М.Д., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Павлова М.С., Хачатрян Л.Г., Осминина М.К., Геппе Н.А., Подчерняева Н.С., Трепилец В.М., Богданова М.Д., Касанаве Е.В., Тюрина Е.Н., Великорецкая М.Д.</copyright-holder><copyright-holder xml:lang="en">Pavlova M.S., Khachatryan L.G., Osminina M.K., Geppe N.A., Podchernyaeva N.S., Trepilets V.M., Bogdanova M.D., Kasanave E.V., Tjurina E.N., Velikoretskaya M.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.lvrach.ru/jour/article/view/176">https://journal.lvrach.ru/jour/article/view/176</self-uri><abstract><p>В структуре заболеваемости, среди ревматических заболеваний у детей, ювенильная склеродермия (ЮСД) занимает третье место по частоте после ювенильного идиопатического артрита и системной красной волчанки. Своевременная постановка диагноза ЮСД представляет собой определенные трудности, поскольку традиционные критерии для постановки диагноза склеродермии применимы к взрослым пациентам. В отличие от взрослых пациентов, у детей в начальном периоде заболевания реже встречается поражение внутренних органов, а поражение суставов встречается с равной частотой. По данным последних исследований, наиболее частыми неврологическими проявлениями при ЮСД с локализацией поражения на голове и шее являются эпилептические приступы, головные боли, локальный неврологический дефицит, психоэмоциональные и когнитивные нарушения. В процессе настоящего исследования обследован 51 ребенок со склеродермией с локализацией поражения на голове и шее в возрасте от 3 до 17 лет. У большинства пациентов (80%) первым симптомом болезни явилось характерное поражение кожи в виде лилового пятна, с последующей индурацией тканей линейной формы, реже заболевание начиналось с появления участка алопеции на волосистой части головы или в области бровей. Склеродермия с поражениями на голове и шее является наиболее тяжелой формой из всех локализованных видов склеродермии и может быть приравнена по тяжести своего течения к ее генерализованным формам. Палитра полисистемных нарушений при этой форме требует мультидисциплинарного подхода в обследовании и терапии. В перечень обязательных методов обследования при склеродермии лица и шеи должны быть включены магнитно-резонансная томография головного мозга, электроэнцефалография и психологическое обследование.</p></abstract><trans-abstract xml:lang="en"><p>In the structure of morbidity, among rheumatic diseases in children, juvenile scleroderma takes the third place in frequency after juvenile idiopathic arthritis and systemic lupus erythematosus. Timely diagnosis of juvenile scleroderma presents certain difficulties, since the traditional criteria for making a diagnosis of scleroderma are applicable to adult patients. Unlike adult patients, in the initial period of the disease, lesions of the internal organs are less likely to occur, and joint damage occurs with equal frequency. According to recent studies, the most common neurological manifestations in juvenile scleroderma with localization of lesions on the head and neck are epileptic seizures, headaches, local neurological deficits, psychoemotional and cognitive impairments. In the course of this study, 51 children with scleroderma with localization of lesions on the head and neck at the age of 3 to 17 years were examined. In most patients (80%), the first symptom of the disease was a characteristic skin lesion in the form of a purple spot, followed by linear tissue induction, less often the disease began with the appearance of an alopecia on the scalp or in the eyebrow area. Scleroderma with lesions on the head and neck is the most severe form of all localized types of scleroderma and can be equated in its severity with its generalized forms. The palette of polysystemic disorders in this form requires a multidisciplinary approach in examination and therapy. The list of mandatory examination methods for scleroderma of the face and neck should include brain MRI, EEG and psychological examination. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>Дети</kwd><kwd>Неврологические нарушения</kwd><kwd>Педиатрия</kwd><kwd>Психологическое состояние</kwd><kwd>Психоневрология</kwd><kwd>Склеродермия лица и шеи</kwd><kwd>Страничка педиатра</kwd></kwd-group><kwd-group xml:lang="en"><kwd>scleroderma of the face and neck</kwd><kwd>children</kwd><kwd>psychological state</kwd><kwd>neurological disorders</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zulian F. Scleroderma in children // Best Practice &amp; Research Clinical Rheumatology. 2017; 31, (4): 439-610.</mixed-citation><mixed-citation xml:lang="en">Zulian F. Scleroderma in children // Best Practice &amp; Research Clinical Rheumatology. 2017; 31, (4): 439-610.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Herrick A. L., Ennis H., Bhushan M., Silman A. J., Baildam E. M. Incidence of childhood linear scleroderma and systemic sclerosis // Arthritis Care Res. 2010; 62: 213e8.</mixed-citation><mixed-citation xml:lang="en">Herrick A. L., Ennis H., Bhushan M., Silman A. J., Baildam E. M. Incidence of childhood linear scleroderma and systemic sclerosis // Arthritis Care Res. 2010; 62: 213e8.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zulian F., Martini G. Childhood systemic sclerosis // Current Opinion in Rheumatology. 2007; 19 (6): 592-597.</mixed-citation><mixed-citation xml:lang="en">Zulian F., Martini G. Childhood systemic sclerosis // Current Opinion in Rheumatology. 2007; 19 (6): 592-597.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Martini G., Foeldvari I., Russo R., Cuttica R., Eberhard A., Ravelli A., et al. Systemic sclerosis in childhood: clinical and immunological features of 153 patients in an international database // Arthritis Rheum. 2006; 54: 3971-3978.</mixed-citation><mixed-citation xml:lang="en">Martini G., Foeldvari I., Russo R., Cuttica R., Eberhard A., Ravelli A., et al. Systemic sclerosis in childhood: clinical and immunological features of 153 patients in an international database // Arthritis Rheum. 2006; 54: 3971-3978.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Preliminary criteria for the classification of systemic sclerosis (scleroderma). Committee, The Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria // Arthritis Rheum. 1980; 23: 581-590.</mixed-citation><mixed-citation xml:lang="en">Preliminary criteria for the classification of systemic sclerosis (scleroderma). Committee, The Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria // Arthritis Rheum. 1980; 23: 581-590.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Amaral T. M., Peres F. A., Lapa A. T., Marques-Neto J. F., Appenzeller S. Neurological involvement inscleroderma: a systematic review // Semin Arthritis. 2013; 43: 335-347.</mixed-citation><mixed-citation xml:lang="en">Amaral T. M., Peres F. A., Lapa A. T., Marques-Neto J. F., Appenzeller S. Neurological involvement inscleroderma: a systematic review // Semin Arthritis. 2013; 43: 335-347.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">English S. W., Ho M. L., Tollefson M. M., Wong-Kisiel L. C. Focal Epilepsy in a Teenager With Facial Atrophy and Hair Loss // Semin Pediatr Neurol. 2018; 26: 68-73. DOI: 10.1016/j.spen.2017.03.009. Epub 2017 Apr 2.</mixed-citation><mixed-citation xml:lang="en">English S. W., Ho M. L., Tollefson M. M., Wong-Kisiel L. C. Focal Epilepsy in a Teenager With Facial Atrophy and Hair Loss // Semin Pediatr Neurol. 2018; 26: 68-73. DOI: 10.1016/j.spen.2017.03.009. Epub 2017 Apr 2.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rocha R., Kaliakatsos M. Epilepsy in paediatric patients with Parry-Romberg syndrome: A review of the literature // Seizure - European Journal of Epilepsy. 2020, January 27. DOI: https://doi.org/10.1016/j.seizure.2020.01.017.</mixed-citation><mixed-citation xml:lang="en">Rocha R., Kaliakatsos M. Epilepsy in paediatric patients with Parry-Romberg syndrome: A review of the literature // Seizure - European Journal of Epilepsy. 2020, January 27. DOI: https://doi.org/10.1016/j.seizure.2020.01.017.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Беляева Л. М., Чижевская И. Д. Системный склероз и ограниченная склеродермия у детей и подростков // Педиатрия. Журнал им. Г. Н. Сперанского. 2009, № 5. @@Belyayeva L. M., Chizhevskaya I. D. Sistemnyy skleroz i ogranichennaya sklerodermiya u detey i podrostkov (Systemic sclerosis and limited scleroderma in children and adolescents.) Pediatriya. Zhurnal im. G. N. Speranskogo. 2009, № 5.</mixed-citation><mixed-citation xml:lang="en">Беляева Л. М., Чижевская И. Д. Системный склероз и ограниченная склеродермия у детей и подростков // Педиатрия. Журнал им. Г. Н. Сперанского. 2009, № 5. @@Belyayeva L. M., Chizhevskaya I. D. Sistemnyy skleroz i ogranichennaya sklerodermiya u detey i podrostkov (Systemic sclerosis and limited scleroderma in children and adolescents.) Pediatriya. Zhurnal im. G. N. Speranskogo. 2009, № 5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Baubet T., Ranque B., Taieb O., et al. Mood and anxiety disorders in systemic sclerosis patients // Presse Med. 2011; 40: e111-119.</mixed-citation><mixed-citation xml:lang="en">Baubet T., Ranque B., Taieb O., et al. Mood and anxiety disorders in systemic sclerosis patients // Presse Med. 2011; 40: e111-119.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Blaszczyk M., Krolicki L., Krasu M., Glinska O., Jablonska S. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre // J Rheumatol. 2003; 30 (9): 1997-2004. [Epub2003/09/11].</mixed-citation><mixed-citation xml:lang="en">Blaszczyk M., Krolicki L., Krasu M., Glinska O., Jablonska S. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre // J Rheumatol. 2003; 30 (9): 1997-2004. [Epub2003/09/11].</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Jewett L. R., Razykov I., Hudson M., et al, Canadian Scleroderma Research Group. Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis // Rheumatology. 2014; 53: 1719.</mixed-citation><mixed-citation xml:lang="en">Jewett L. R., Razykov I., Hudson M., et al, Canadian Scleroderma Research Group. Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis // Rheumatology. 2014; 53: 1719.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kwakkenbos L., Delisle V. C., Fox R. S., Gholizadeh S., Jewett L. R., Levis B., Milette K., Mills S. D., Malcarne V. L., Thombs B. D. Psychosocial Aspects of Scleroderma // Rheum Dis Clin North Am. 2015; 41 (3): 519-528. DOI: 10.1016/j.rdc.2015.04.010. Epub 2015 May 27.</mixed-citation><mixed-citation xml:lang="en">Kwakkenbos L., Delisle V. C., Fox R. S., Gholizadeh S., Jewett L. R., Levis B., Milette K., Mills S. D., Malcarne V. L., Thombs B. D. Psychosocial Aspects of Scleroderma // Rheum Dis Clin North Am. 2015; 41 (3): 519-528. DOI: 10.1016/j.rdc.2015.04.010. Epub 2015 May 27.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bragazzi N. L., Watadd A., Gizuntermang A., McGonagle D., Mahagnad H., Comaneshterh D., Amitald H., Cohen A. D., Amital D. The burden of depression in systemic sclerosis patients: a nationwide population-based study // Journal of Affective Disorders. 2019; 243: 427-431.</mixed-citation><mixed-citation xml:lang="en">Bragazzi N. L., Watadd A., Gizuntermang A., McGonagle D., Mahagnad H., Comaneshterh D., Amitald H., Cohen A. D., Amital D. The burden of depression in systemic sclerosis patients: a nationwide population-based study // Journal of Affective Disorders. 2019; 243: 427-431.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Paprocka J., Jamroz E., Adamek D., Marszal E., Mandera M. Difficulties in differentiation entiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome // Childs Nerv Syst. 2006; 22 (4): 409-415 [Epub2005/10/26].</mixed-citation><mixed-citation xml:lang="en">Paprocka J., Jamroz E., Adamek D., Marszal E., Mandera M. Difficulties in differentiation entiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome // Childs Nerv Syst. 2006; 22 (4): 409-415 [Epub2005/10/26].</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Verhelst H. E., Beele H., Joos R., Vanneuville B., Van Coster R. N. Hippocampal atrophy and developmental regression as first sign of linear scleroderma «en coup desabre» // Eur J Paediatr Neurol. 2008; 12 (6): 508-511 [Epub2008/01/22].</mixed-citation><mixed-citation xml:lang="en">Verhelst H. E., Beele H., Joos R., Vanneuville B., Van Coster R. N. Hippocampal atrophy and developmental regression as first sign of linear scleroderma «en coup desabre» // Eur J Paediatr Neurol. 2008; 12 (6): 508-511 [Epub2008/01/22].</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson L. E., Treat J. R., Licht D. J., Kreiger P. A., Knight A. M. Remission of seizures with immunosuppressive therapy in Parry?Romberg syndrome anden coup de sabre linear scleroderma: Case report and briefreview of the literature // Pediatr Dermatol. 2018, and 00: 1-3.</mixed-citation><mixed-citation xml:lang="en">Anderson L. E., Treat J. R., Licht D. J., Kreiger P. A., Knight A. M. Remission of seizures with immunosuppressive therapy in Parry?Romberg syndrome anden coup de sabre linear scleroderma: Case report and briefreview of the literature // Pediatr Dermatol. 2018, and 00: 1-3.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fain E. T., Mannion M., Pope E., Young D. W., Laxer R. M., Cron R. Q. Brain cavernomas associated with en coup de sabre linear scleroderma: two case reports // Pediatr Rheumatol Online J. 2011; 9: 18.</mixed-citation><mixed-citation xml:lang="en">Fain E. T., Mannion M., Pope E., Young D. W., Laxer R. M., Cron R. Q. Brain cavernomas associated with en coup de sabre linear scleroderma: two case reports // Pediatr Rheumatol Online J. 2011; 9: 18.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Korkmaz C., Adapinar B., Uysal S. Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature // South Med J. 2005; 98.</mixed-citation><mixed-citation xml:lang="en">Korkmaz C., Adapinar B., Uysal S. Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature // South Med J. 2005; 98.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Осминина М. К., Геппе Н. А. Вопросы классификации, клиническая картина и базисная терапия ювенильной склеродермии // Научно-практическая ревматология. 2015; 53(2): 214-219. https://doi.org/10.14412/1995-4484-2015-214-219. @@Osminina M. K., Geppe N. A. Voprosy klassifikatsii, klinicheskaya kartina i bazisnaya terapiya yuvenil’noy sklerodermii (Classification questions, clinical picture and basic therapy of juvenile scleroderma.) Nauchno-prakticheskaya revmatologiya. 2015; 53(2): pp 214-219. https://doi.org/10.14412/1995-4484-2015-214-219.</mixed-citation><mixed-citation xml:lang="en">Осминина М. К., Геппе Н. А. Вопросы классификации, клиническая картина и базисная терапия ювенильной склеродермии // Научно-практическая ревматология. 2015; 53(2): 214-219. https://doi.org/10.14412/1995-4484-2015-214-219. @@Osminina M. K., Geppe N. A. Voprosy klassifikatsii, klinicheskaya kartina i bazisnaya terapiya yuvenil’noy sklerodermii (Classification questions, clinical picture and basic therapy of juvenile scleroderma.) Nauchno-prakticheskaya revmatologiya. 2015; 53(2): pp 214-219. https://doi.org/10.14412/1995-4484-2015-214-219.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kowal-Bielecka O., Fransen J., Avouac J., Becker M., Kulak A., Allanore Y., et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017;76:1327-39.</mixed-citation><mixed-citation xml:lang="en">Kowal-Bielecka O., Fransen J., Avouac J., Becker M., Kulak A., Allanore Y., et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017;76:1327-39.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lythgoe H., Baildam E., Beresford M. W., Cleary G., McCann L. J., Pain C. E. Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma // Rheumatology (Oxford). 2018; 57 (2): 398-401. DOI: 10.1093/rheumatology/kex382.</mixed-citation><mixed-citation xml:lang="en">Lythgoe H., Baildam E., Beresford M. W., Cleary G., McCann L. J., Pain C. E. Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma // Rheumatology (Oxford). 2018; 57 (2): 398-401. DOI: 10.1093/rheumatology/kex382.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Magro C. M., Halteh P., Olson L. C., Kister I., Shapiro L. Linear scleroderma «en coup de sabre» with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy // Orphanet J Rare Dis. 2019; 14 (1): 110. DOI: 10.1186/s13023-019-1015-7.</mixed-citation><mixed-citation xml:lang="en">Magro C. M., Halteh P., Olson L. C., Kister I., Shapiro L. Linear scleroderma «en coup de sabre» with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy // Orphanet J Rare Dis. 2019; 14 (1): 110. DOI: 10.1186/s13023-019-1015-7.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Tashkin D. P., Roth M. D., Clements P. J., Furst D. E., Khanna D., Kleerup E. C., et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial // Lancet Respir Med. 2016; 4: 708-719.</mixed-citation><mixed-citation xml:lang="en">Tashkin D. P., Roth M. D., Clements P. J., Furst D. E., Khanna D., Kleerup E. C., et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial // Lancet Respir Med. 2016; 4: 708-719.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Beck A. T. et al. An Inventory for Measuring Depression //Archives of general psychiatry. - 1961. - Т. 4. - №. 6. - С. 561-571.</mixed-citation><mixed-citation xml:lang="en">Beck A. T. et al. An Inventory for Measuring Depression //Archives of general psychiatry. - 1961. - Т. 4. - №. 6. - С. 561-571.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Beck AT, Epstein N, Brown G, Steer RA (1988). «An inventory for measuring clinical anxiety: Psychometric properties». Journal of Consulting and Clinical Psychology. 56 (6): 893-897. doi:10.1037/0022-006x.56.6.893.</mixed-citation><mixed-citation xml:lang="en">Beck AT, Epstein N, Brown G, Steer RA (1988). «An inventory for measuring clinical anxiety: Psychometric properties». Journal of Consulting and Clinical Psychology. 56 (6): 893-897. doi:10.1037/0022-006x.56.6.893.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Шкала явной тревожности для детей 8-12 лет (CMAS) / пер. А.М. Прихожан; отв. за выпуск В.Э. Пахальян. - Москва: Лаборатория научных основ детской практической психологии Психологического института РАО, 1994. - (Диагностический банк школьного психолога; выпуск 9) @@Shkala yavnoy trevozhnosti dlya detey 8-12 let (CMAS) (The apparent anxiety scale for children 8-12 years old (CMAS)) per. A.M. Prikhozhan; otv. za vypusk V.E. Pakhal’yan. - Moskva: Laboratoriya nauchnykh osnov detskoy prakticheskoy psikhologii Psikhologicheskogo instituta RAO, 1994. - (Diagnosticheskiy bank shkol’nogo psikhologa; vypusk 9)</mixed-citation><mixed-citation xml:lang="en">Шкала явной тревожности для детей 8-12 лет (CMAS) / пер. А.М. Прихожан; отв. за выпуск В.Э. Пахальян. - Москва: Лаборатория научных основ детской практической психологии Психологического института РАО, 1994. - (Диагностический банк школьного психолога; выпуск 9) @@Shkala yavnoy trevozhnosti dlya detey 8-12 let (CMAS) (The apparent anxiety scale for children 8-12 years old (CMAS)) per. A.M. Prikhozhan; otv. za vypusk V.E. Pakhal’yan. - Moskva: Laboratoriya nauchnykh osnov detskoy prakticheskoy psikhologii Psikhologicheskogo instituta RAO, 1994. - (Diagnosticheskiy bank shkol’nogo psikhologa; vypusk 9)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Тест тревожности (Р.Тэммл, М.Дорки, В.Амен) / Дерманова И.Б. Диагностика эмоционально-нравственного развития - СПб., 2002. С.19-28. @@Test trevozhnosti (R.Temml, M.Dorki, V.Amen) (Anxiety test) Dermanova I.B. Diagnostika emotsional’no-nravstvennogo razvitiya - SPb., 2002. pp.19-28.</mixed-citation><mixed-citation xml:lang="en">Тест тревожности (Р.Тэммл, М.Дорки, В.Амен) / Дерманова И.Б. Диагностика эмоционально-нравственного развития - СПб., 2002. С.19-28. @@Test trevozhnosti (R.Temml, M.Dorki, V.Amen) (Anxiety test) Dermanova I.B. Diagnostika emotsional’no-nravstvennogo razvitiya - SPb., 2002. pp.19-28.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Векслер Д. Шкала интеллекта Векслера для детей. WISC Wechsler Intelligence Scale for Children. Руководство. Челябинск 2003. @@Veksler D. Shkala intellekta Vekslera dlya detey. WISC Wechsler Intelligence Scale for Children. Rukovodstvo. Chelyabinsk 2003.</mixed-citation><mixed-citation xml:lang="en">Векслер Д. Шкала интеллекта Векслера для детей. WISC Wechsler Intelligence Scale for Children. Руководство. Челябинск 2003. @@Veksler D. Shkala intellekta Vekslera dlya detey. WISC Wechsler Intelligence Scale for Children. Rukovodstvo. Chelyabinsk 2003.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Чижевская И. Д., Беляева Л. М. Психологические особенности детей с различными формами склеродермии // Научно-практическая ревматология. 2006, № 2. @@Chizhevskaya I. D., Belyayeva L. M. Psikhologicheskiye osobennosti detey s razlichnymi formami sklerodermii (Psychological features of children with various forms of scleroderma.) Nauchno-prakticheskaya revmatologiya. 2006, № 2.</mixed-citation><mixed-citation xml:lang="en">Чижевская И. Д., Беляева Л. М. Психологические особенности детей с различными формами склеродермии // Научно-практическая ревматология. 2006, № 2. @@Chizhevskaya I. D., Belyayeva L. M. Psikhologicheskiye osobennosti detey s razlichnymi formami sklerodermii (Psychological features of children with various forms of scleroderma.) Nauchno-prakticheskaya revmatologiya. 2006, № 2.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Stasiulis E., Gladstone B., Boydell K., O’Brien C., Pope E., Laxer RM. Children with facial morphoea managing everyday life: a qualitative study // Br J Dermatol. 2018; 179 (2): 353-361. DOI: 10.1111/bjd.16449. Epub 2018 Jun 7.</mixed-citation><mixed-citation xml:lang="en">Stasiulis E., Gladstone B., Boydell K., O’Brien C., Pope E., Laxer RM. Children with facial morphoea managing everyday life: a qualitative study // Br J Dermatol. 2018; 179 (2): 353-361. DOI: 10.1111/bjd.16449. Epub 2018 Jun 7.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sierakowska M., Doroszkiewicz H., Sierakowska J., Olesi?ska M., Grabowska-Jodkowska A., Brzosko M., Leszczyski P., Pawlak-Bu? K., Batko B., Wiland P., Majdan M., Bykowska-Sochacka M., Romanowski W., Zon-Giebel A., Jeka S., Ndosi M. Factors associated with quality of life in systemic sclerosis: a cross-sectional study // Qual Life Res. 2019; 28 (12): 3347-3354. DOI: 10.1007/s11136-019-02284-9. Epub 2019 Sep 3.</mixed-citation><mixed-citation xml:lang="en">Sierakowska M., Doroszkiewicz H., Sierakowska J., Olesi?ska M., Grabowska-Jodkowska A., Brzosko M., Leszczyski P., Pawlak-Bu? K., Batko B., Wiland P., Majdan M., Bykowska-Sochacka M., Romanowski W., Zon-Giebel A., Jeka S., Ndosi M. Factors associated with quality of life in systemic sclerosis: a cross-sectional study // Qual Life Res. 2019; 28 (12): 3347-3354. DOI: 10.1007/s11136-019-02284-9. Epub 2019 Sep 3.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
